Annual Report Pursuant to Regulation a (1-k)

Form 1-K Issuer Information

FORM 1-K

UNITED STATE

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 1-K

OMB APPROVAL

OMB Number:  ####-####

Estimated average burden hours per response: ##.#

1-K: Filer Information

Issuer CIK

0001139685 

Issuer CCC

XXXXXXXX 

Is filer a shell company?

o Yes x No

Is the electronic copy of an official filing submitted in paper format?

o

File Number

 

Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination?

o Yes x No

Successor File Number

 

Is this a LIVE or TEST Filing?

x LIVE o TEST

Would you like a Return Copy?

o

Period

12-31-2022 

Submission Contact Information

Name

 

Phone

 

E-Mail Address

 

Notify via Filing Website only?

o

1-K: Tab 1 Notification

This Form 1-K is to provide an

x Annual Report o Special Financial Report for the fiscal year

Fiscal Year End

12-31-2022 

Exact name of issuer as specified in the issuer's charter

20/20 GeneSystems, Inc. 

CIK

0001139685 

Jurisdiction of Incorporation / Organization

DELAWARE  

I.R.S. Employer Identification Number

57-2272107 

Address of Principal Executive Offices

Address 1

15810 Gaither Road 

Address 2

Suite 235 

City

Gaithersburg 

State/Country

MARYLAND  

Mailing Zip/ Postal Code

20877 

Phone

240-453-6339 

Title of each class of securities issued pursuant to Regulation A

Series B Preferred Stock and Series C Preferred Stock